01 1Centaur Pharmaceuticals
01 1CHLORZOXAZONE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-07-31
Pay. Date : 2018-06-20
DMF Number : 32112
Submission : 2017-09-29
Status : Active
Type : II
20
Centaur Pharmaceuticals Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CHLORZOXAZONE USP, with a corresponding US DMF Number 32112.
Remarkably, this DMF maintains an Active status since its submission on September 29, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 31, 2018, and payment made on June 20, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
